StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
AAWH

Ascend Wellness Holdings, Inc.

AAWH OTC Medicinal Chemicals & Botanical Products EDGAR ↗
$0.38
-0.01 -1.82%

Key statistics

from XBRL data in SEC filings
Market cap
$76.7M
Revenue (TTM)
$490M
Net income (TTM)
-$128M
EPS (TTM)
$-0.64
P/E ratio
Dividend yield
Free cash flow
$12.0M
Cash
$60.9M
Total assets
$872M
Gross margin
35.7%
52-week range
$0.36 – $1.20

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Amended charter or bylaws Jun 25, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results May 5, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Other events Feb 13, 2026 8-K Results of operations (earnings release) Feb 9, 2026 8-K Other events Feb 6, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Took on a direct financial obligation; Other events May 28, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Shareholder vote results May 2, 2025 8-K Changed accountants Mar 21, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Results of operations (earnings release) Mar 12, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jan 14, 2025 8-K Other events Dec 27, 2024 8-K Other events Dec 17, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Director or officer change; Regulation FD disclosure Aug 28, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 5, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Other events Jul 22, 2024 8-K Other events Jul 15, 2024 8-K Director or officer change; Regulation FD disclosure May 31, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release); Shareholder vote results May 7, 2024 8-K Director or officer change Apr 2, 2024 10-K Fiscal year ended 2023-12-31 Mar 13, 2024 8-K Results of operations (earnings release) Mar 12, 2024 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release) Nov 7, 2023 8-K Results of operations (earnings release); Director or officer change Oct 25, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023